Authors:
Pincus, T
Koch, GG
Sokka, T
Lefkowith, J
Wolfe, F
Jordan, JM
Luta, G
Callahan, LF
Wang, X
Schwartz, T
Abramson, SB
Caldwell, JR
Harrell, RA
Kremer, JM
Lautzenheiser, RL
Markenson, JA
Schnitzer, TJ
Weaver, A
Cummins, P
Wilson, A
Morant, S
Fort, J
Citation: T. Pincus et al., A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee, ARTH RHEUM, 44(7), 2001, pp. 1587-1598
Citation: Pj. Mroczkowski et al., Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. S66-S68
Citation: Jm. Kremer, Methotrexate and leflunomide: Biochemical basis for combination therapy inthe treatment of rheumatoid arthritis, SEM ARTH RH, 29(1), 1999, pp. 14-26
Authors:
Weinblatt, ME
Kremer, JM
Bankhurst, AD
Bulpitt, KJ
Fleischmann, RM
Fox, RI
Jackson, CG
Lange, M
Burge, DJ
Citation: Me. Weinblatt et al., A trial of etanercept, a recombinant tumor necrosis factor receptor : Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate, N ENG J MED, 340(4), 1999, pp. 253-259
Authors:
Walsh, JD
Blanchard, EB
Kremer, JM
Blanchard, CG
Citation: Jd. Walsh et al., The psychosocial effects of rheumatoid arthritis on the patient and the well partner, BEHAV RES T, 37(3), 1999, pp. 259-271
Authors:
Weinblatt, ME
Kremer, JM
Coblyn, JS
Maier, AL
Helfgott, SM
Morrell, M
Byrne, VM
Kaymakcian, MV
Strand, V
Citation: Me. Weinblatt et al., Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis, ARTH RHEUM, 42(7), 1999, pp. 1322-1328
Citation: T. Pincus et al., Combination therapy with multiple disease-modifying antirheumatic drugs inrheumatoid arthritis: A preventive strategy, ANN INT MED, 131(10), 1999, pp. 768-774